Notice of Results

RNS Number : 3760J
e-Therapeutics plc
29 June 2011
 



 

e-Therapeutics plc

 

Notice of Preliminary Results

 

 

e-Therapeutics plc (AIM: ETX), the drug discovery and development company, will be announcing its final results for the 12 month period ending 31st January 2011 on Monday 25th July 2011.

 

Professor Malcolm Young, CEO, Daniel Elger, CFO, and Stephen Self, Development Director, will be hosting a presentation for analysts at 9.30am on the morning of the results at the offices of College Hill, The Registry, Royal Mint Court, EC3N 4QN.    

 

-Ends-

 

For more information, please contact:

 

e-Therapeutics plc

Malcolm Young

Tel: +44 (0) 191 233 1317

Daniel Elger

Tel: +44 (0) 7909 915 068

www.etherapeutics.co.uk 

 

Panmure Gordon (UK) Limited

Andrew Burnett / Aubrey Powell

Tel: +44 (0) 20 7459 3600

www.panmure.com

 

College Hill

Melanie Toyne Sewell/Jayne Crook

Tel: +44 (0) 20 7457 2020

Email: e-therapeutics@collegehill.com

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORXKLFLFQFXBBD
UK 100

Latest directors dealings